Minimally Invasive Ablation of a Toxic Thyroid Nodule by High-Intensity Focused Ultrasound

References

1. 1.↵
   1. Biondi B,
   2. Palmieri EA,
   3. Klain M,
   4. et al

   . Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 2005;152:1–9

   Abstract/FREE Full Text
2. 2.↵
   1. Gharib H,
   2. Tuttle RM,
   3. Baskin HJ,
   4. et al

   . Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005;90:581–85, discussion 586-87

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Guglielmi R,
   2. Pacella CM,
   3. Bianchini A,
   4. et al

   . Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 2004;14:125–31

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Tarantino L,
   2. Francica G,
   3. Sordelli I,
   4. et al

   . Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients. AJR Am J Roentgenol 2008;190:800–08

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Baek JH,
   2. Jeong HJ,
   3. Kim YS,
   4. et al

   . Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid 2008;18:675–76

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Pacella CM,
   2. Bizzarri G,
   3. Spiezia S,
   4. et al

   . Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 2004;232:272–80

   PubMedWeb of Science
7. 7.↵
   1. Cakir B,
   2. Gul K,
   3. Ugras S,
   4. et al

   . Percutaneous laser ablation of an autonomous thyroid nodule: effects on nodule size and histopathology of the nodule 2 years after the procedure. Thyroid 2008;18:803–05

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Chapelon JY,
   2. Margonari J,
   3. Theillere Y,
   4. et al

   . Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol 1992;22:147–52

   PubMedWeb of Science
9. 9.↵
   1. Wu F,
   2. Wang ZB,
   3. Zhu H,
   4. et al

   . Extracorporeal high intensity focused ultrasound treatment for patients with breast cancer. Breast Cancer Res Treat 2005;92:51–60

   CrossRefPubMed
10. 10.↵
    1. Rouviere O,
    2. Souchon R,
    3. Salomir R,
    4. et al

    . Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging. Eur J Radiol 2007;63:317–27

    CrossRefPubMed
11. 11.↵
    1. Esnault O,
    2. Franc B,
    3. Monteil JP,
    4. et al

    . High-intensity focused ultrasound for localized thyroid-tissue ablation: preliminary experimental animal study. Thyroid 2004;14:1072–76

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Dossing H,
    2. Bennedbaek FN,
    3. Hegedus L

    . Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules: one versus three treatments. Thyroid 2006;16:763–68

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Cakir B,
    2. Topaloglu O,
    3. Gul K,
    4. et al

    . Effects of percutaneous laser ablation treatment in benign solitary thyroid nodules on nodule volume, thyroglobulin and anti-thyroglobulin levels, and cytopathology of nodule in 1 yr follow-up. J Endocrinol Invest 2006;29:876–84

    PubMedWeb of Science
14. 14.↵
    1. Hacker A,
    2. Michel MS,
    3. Marlinghaus E,
    4. et al

    . Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int 2006;97:779–85

    CrossRefPubMed
15. 15.↵
    1. Li JJ,
    2. Xu GL,
    3. Gu MF,
    4. et al

    . Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors. World J Gastroenterol 2007;13:2747–51

    PubMed